In the UK, patients who have not responded to traditional treatments for trigeminal neuralgia may be eligible for cannabis-based options through private healthcare clinics, like Releaf. This is because medical cannabis has demonstrated great potential in reducing pain severity, improving health related quality of life, emotional wellbeing, and sleep quality.
While there are only a limited number of studies that investigate the direct effects cannabinoid containing treatments can have on trigeminal neuralgia symptoms, there is sufficient supporting evidence that demonstrates its potential in treating pain, addressing sleep concerns, and reducing anxiety.
Surveys of patients with trigeminal neuralgia that have tried cannabis-based treatments do boast positive results and these treatments are usually well tolerated, with 81% of those involved in a US survey reporting an improvement in their symptoms following medical cannabis application.
But while clinical evidence and randomised controlled trials are still currently lacking in this area, it is important that medical cannabis applications are carefully monitored by qualified healthcare professionals. To find out if trigeminal neuralgia medical cannabis treatments may be right for you, fill out our eligibility checker.